Cue Biopharma, Inc. Quarterly Unrecognized Tax Benefits in USD from Q4 2017 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Cue Biopharma, Inc. quarterly Unrecognized Tax Benefits history and growth rate from Q4 2017 to Q4 2023.
  • Cue Biopharma, Inc. Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $2.93M, a 17.5% increase year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $2.93M +$436K +17.5% Dec 31, 2023 10-K 2024-03-28
Q4 2022 $2.49M +$423K +20.5% Dec 31, 2022 10-K 2024-03-28
Q4 2021 $2.07M +$393K +23.5% Dec 31, 2021 10-K 2024-03-28
Q4 2020 $1.68M +$341K +25.6% Dec 31, 2020 10-K 2023-03-21
Q4 2019 $1.33M +$362K +37.2% Dec 31, 2019 10-K 2022-03-16
Q4 2018 $972K +$462K +90.6% Dec 31, 2018 10-K 2021-03-09
Q4 2017 $510K Dec 31, 2017 10-K 2020-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.